USANA enters Mexico
This article was originally published in The Tan Sheet
Executive Summary
Direct marketer will "begin operations and selling products to new associates in Mexico" in Q1 2004, firm says March 4. "The opening of Mexico will give USANA a presence in each of the four largest direct sales markets in the world" and is "another important step in our global expansion efforts," President Dave Wentz says. USANA entered Taiwan in Q3 2002 and announced plans to expand into Korea in mid-2003 (1"The Tan Sheet" Feb. 10, 2003, p. 10)...
You may also be interested in...
Sales & Earnings In Brief
Bausch & Lomb: Worldwide lens care sales rose 8% to $121 mil. in Q4, led by ReNu products' double-digit gains in the Americas and Asia, according to Jan. 30 1company announcement. For the year, lens care revenues advanced 12% to $465.5 mil. Positive lens care performance, along with similar strong gains in contact lens and pharmaceuticals sales, helped power 9% overall sales increase to $1.81 bil. in 2002 versus the previous year, firm reports; full year net earnings rose to $72.5 mil. in 2002 from $21.2 mil. a year ago. B&L expects "low single-digit growth in" lens care sales in 2003. Additionally, Chairman & CEO Ronald Zarrella will oversee firm's Americas region commercial business until a successor is named for B&L exec Mark Sieczkarek, who left Jan. 31 "to pursue career opportunities elsewhere"...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.